Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus +/- Trastuzumab in Hormone-Refractory Metastatic Breast Cancer
NCT00912340Phase 2Completed
- Sponsor
- Emory University
- Start
- May 2009
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Emory University. Started May 2009; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00912340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912340.